Compare SCCM vs CHEST
| 8.7 SCCM | 7.6 CHEST | |
|---|---|---|
| Score | ||
| Buzzbox Score | 8.7 (Excellent) | 7.6 (Strong) |
| Event Details | ||
| Dates | March 22-24, 2026 | October 18-21, 2026 |
| Location | McCormick Place West Building, Chicago, IL | Phoenix Convention Center, Phoenix, AZ |
| Scale | large | large |
| Audience | ||
| Attendees | 5,000 | 5,000 |
| Exhibitors | n/a | n/a |
| Purchasing authority | ~50% | ~50% |
| Effective buyers | 2,500 | 2,500 |
| Costs | ||
| $/sqft | $46 | n/a |
| 10×10 space | $4,600 | n/a |
| All-in estimate | n/a | Est. $12,000-$22,000 |
| Cost per buyer | n/a | $6.8 |
Why exhibit at SCCM
The largest multiprofessional critical care conference in the US, drawing 5,000+ ICU clinicians who directly influence ventilator, monitoring, and infusion system purchasing. McCormick Place venue keeps logistics simple for large booth builds.
Why exhibit at CHEST
The leading clinical meeting for chest medicine. While ATS skews academic/research, CHEST is where practicing pulmonologists and critical care physicians come for hands-on clinical education. More clinically actionable audience means better buyer intent for device and equipment vendors. Excellent for bronchoscopy, ventilation, and respiratory monitoring companies.
Why skip SCCM
Heavy academic orientation means many attendees are residents, fellows, and researchers with limited purchasing authority. Exhibitor count is modest (130) reflecting a focused but smaller expo floor compared to mega shows like HIMSS or RSNA.
Why skip CHEST
Smaller than ATS (5,000 vs 10,500) so raw lead volume will be lower. Same audience overlap -- many attendees go to both ATS and CHEST. If budget is tight, pick one.